PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: AnaSpec, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

AnaSpec Introduces Sixty New Peptides & 3 New Assay Kits - This week, AnaSpec introduced sixty (60) new catalog peptides and three (3) new assay kits
AnaSpec Introduces Sixty New Peptides & 3 New Assay Kits

 

NewswireToday - /newswire/ - San Jose, CA, United States, 2008/05/23 - This week, AnaSpec introduced sixty (60) new catalog peptides and three (3) new assay kits.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

This week AnaSpec introduced sixty new peptides and three new assay kits:

[Phe668]-Amyloid Precursor Protein (APP) (659-676),
Beta-Amyloid (17-21)-Lys(Biotin)
Protein G B1 Domain (41-56), beta-hairpin
[Glu3]-RGES, Control for RGD Peptides
Coagulation factor IX Fragment A
Cytomegalovirus Proteinase Substrate
SMR1-Related Undecapeptide
P. falciparum Liver-Stage Antigen 3-NRI
Survivin (85–93)
[pSer155]-BAD BH3 (146-159)
Bak BH3 (73-87)
2Wp, Class II MHC Molecule
LCMV (2062-2069)
EBV 2A.32
PLL (889–900), H/K-ATPase alpha-Chain Peptide (889–900)
[Asn670, Leu671]-Amyloid Precursor Protein (APP) (668-676), Swedish Mutation
Biotin-beta-Amyloid (18-28)
Biotin-LC-beta-Amyloid (22-41)
HspB8 (181-194)
Chimeric Rabies Virus Glycoprotein Fragment
Mastoparan X
Nociceptin (1-11)
Nociceptin (1-7)
Prepronociceptin (169-176), human
Fibronectin (1906-1924)
Fibronectin (1946-1960), FN-C/H2
Fibronectin (1951-1960), FN-C/H2-COOH
Fibronectin (1954-1960)
YRGDS Fibronectin Fragment
Cyclo (-RADfK-), RGD negative control
Leptin (22-56), human
V3 gp120 HIV (AD-11)
V3 gp120 HIV (WM)
PAR-3 (1-6), human
Caloxin 2A1
Caloxin 3A1
HBVpol575HBV polymerase (575-583)
Hexon Protein Fragment
MBP (131–155)
MBP (146–170), Myelin Basic Protein (146–170)
GSM Peptide
Neuropeptide S, NPS, chicken
Neuropeptide S, NPS, chimpanzee, dog
TRPA1, C-terminal fragment
Histone 4 (1-21)-Lys(Biotin)
BAD (NT-1)
Metalnikowin I
flg15, Flagellin Fragment
flg15-delta-4, Flagellin Fragment
[pThr145]-p21 (140-147)
Cys-p21 (139–154)
Maspin Reactive Site Loop (RSL), (330-345 )
HB-1 (18-41)
p21 (140-147)
MMK-1
NY-ESO-1 (158–180)
Hyaluronan Inhibitor
37, 40 GAP26, Connexin Mimetic
40Gap 27, Connexin Mimetic
43Gap 36, Connexin Mimetic
SensoLyte™ 440 Cathepsin S Assay Kit
SensoLyte™ 520 Cathepsin S Assay Kit
SensoLyte™ 570 Generic MMP Assay Kit

About AnaSpec, Inc.
AnaSpec is a leading provider of integrated proteomics solutions to elite pharmaceutical and academic research institutions throughout the world. AnaSpec specializes in three core technologies: peptides, detection reagents, & combinatorial chemistry.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: AnaSpec, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


AnaSpec Introduces Sixty New Peptides & 3 New Assay Kits

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Ping Yang 
408-452-5055 ping[.]anaspec.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AnaSpec, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From AnaSpec, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)